AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Industry Experts at Infiniti Research Locate Some of the Key Challenges in Manufacturing Regenerative Medicines | Read the Complete Article for More Insights

February 6, 2020 GMT
Industry Experts at Infiniti Research Locate Some of the Key Challenges in Manufacturing Regenerative Medicines | Read the Complete Article for More Insights
Industry Experts at Infiniti Research Locate Some of the Key Challenges in Manufacturing Regenerative Medicines | Read the Complete Article for More Insights

LONDON--(BUSINESS WIRE)--Feb 6, 2020--

A well-known market intelligence company, Infiniti Research, has announced the completion of its latest article on identifying key regenerative medicine manufacturing challenges. This article covers:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200206005603/en/

Identifying Key Regenerative Medicine Manufacturing Challenges. (Graphic: Business Wire)

“Regenerative medicine will transform the way most chronic diseases are treated in the United States,” says a healthcare industry expert at Infiniti Research.

Regenerative medicine is currently the hive of innovation in modern science with far-reaching benefits for big pharma, healthcare systems, and patient outcomes. We can expect a rapid pace of development in the US regenerative medicine market over the next decade. Some of the key factors fueling demand include the increasing investments in R&D activities and the rising incidence of chronic diseases in the country. Leading vendors have enhanced their R&D investments to develop innovative medical therapies, which is driving the overall growth of the market. Furthermore, M&A and strategic alliances among vendors will have a significant impact on the overall market growth and innovation. Nevertheless, the actual delivery of regenerative medicines has proven to be rather challenging with several roadblocks to commercially viable therapies that are capable of catering to unmet clinical needs. In this article, based on a series of discussions with industry analysts at Infiniti Research, we highlight some of the most relevant and pressing manufacturing challenges in regenerative medicine products. According to experts at Infiniti Research, some of the key challenges of manufacturing regenerative medicine includes manufacturing expense, design quality, biomaterials challenges, and supply chain challenges.

The promise of regenerative medicines requires an innovative look at the complete product lifecycle, including the development of an efficient distribution network. Planning to venture into this space? Request a free proposal for comprehensive insights about the market.

You may also like to read some of our recent articles on the pharmaceutical industry:

Request a free brochureto Learn more about our portfolio of solutions

About Infiniti Research

Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit: https://www.infinitiresearch.com/about-us

View source version on businesswire.com:https://www.businesswire.com/news/home/20200206005603/en/

CONTACT: Infiniti Research

Anirban Choudhury

Marketing Manager

US: +1 844 778 0600

UK: +44 203 893 3400

https://www.infinitiresearch.com/contact-us

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Infiniti Research

Copyright Business Wire 2020.

PUB: 02/06/2020 09:47 AM/DISC: 02/06/2020 09:47 AM

http://www.businesswire.com/news/home/20200206005603/en